PIC still mulling Adcock’s $1.3bn CFR deal

Adcock's largest shareholder Public Investment Corporation (PIC) said it will not decide whether to support a $1.3-billion takeover proposal from Chilean drugmaker CFR Pharmaceuticals South Africa until November 4 at the earliest.

"The Public Investment Corporation has not made a decision yet, the transaction is still under consideration," PIC’s Chief Investment Officer Daniel Matjila said. "We’re doing our utmost best to have a position on Monday."

Adcock, South Africa’s largest supplier of hospital products, said yesterday shareholders representing about 45% of its shares had backed the cash and shares deal. As many as 75% of investors will have to vote in favor for the takeover to succeed, Khotso Mokhele, chairperson of Adcock's independent board, said September 11. The PIC, which oversees the pension funds of South African government workers, has a 14% stake in Adcock.

"The PIC vote will be crucial," Wayne McCurrie, a portfolio manager at Momentum Asset Management in Johannesburg. "I don’t see why the deal won’t go through at this stage, I just think some shareholders will wait until the last minute to commit."

CFR, Chile’s largest drugmaker, said in July it would pay R12.6-billion in cash and shares for Adcock as it seeks to expand in other emerging markets. The company said last month it will settle as much as 51 percent to 64.3% of the purchase through cash and the balance with new CFR shares. The transaction works out at R73.51 per Adcock share, according to both companies.


Strategic partner
The PIC would be willing to consider a strategic partner or investor if a cash offer is for 50% plus one share control of Adcock, Matjila said on July 17.

In May Matjila said  the PIC would prefer a South African company to buy the maker of Panado painkillers and Corenza cold medicine.

CFR struck agreements with Adcock’s Swiss partner Baxter Healthcare SA regarding the licensing, distribution and supply of Adcock’s hospital products and with Adcock’s black empowerment partners in South Africa, according to yesterday’s statement.

"This is a high level of support given the fragmented nature of the company’s shareholder base," Adcock said in the statement on Wednesday. "Only a limited number of requested shareholder undertakings are still to be received."

CFR has faced competition from London-based private equity firm Actis and Bidvest, a Johannesburg-based food and car sales company, in the battle to control Adcock.

CFR, which sold shares to the public in Santiago in 2011, bought Laboratorio Franco Colombiano Lafrancol SAS in December for $560-million, giving it the biggest share of the Colombian market. – Bloomberg

These are unprecedented times, and the role of media to tell and record the story of South Africa as it develops is more important than ever. But it comes at a cost. Advertisers are cancelling campaigns, and our live events have come to an abrupt halt. Our income has been slashed.

The Mail & Guardian is a proud news publisher with roots stretching back 35 years. We’ve survived thanks to the support of our readers, we will need you to help us get through this.

To help us ensure another 35 future years of fiercely independent journalism, please subscribe.

Chris Spillane
Chris Spillane works from Barcelona, Spain. ✈ ✈ ✈ ✈ recovering journalist, former @business & @politicoeurope scribbler, views ≠ mine , are we having fun yet? [X] Chris Spillane has over 1885 followers on Twitter.
Advertising

Ramaphosa asks all South Africans to help to avoid 50...

Calling this ‘the gravest crisis in the history of our democracy’, the president said level three lockdown remains, but enforcement will be strengthened

Reinstated Ingonyama Trust managers hit with retrenchment notices

The effect of Covid-19 and the land reform department’s freeze of R23-million because the ITB didn’t comply with budget submissions are cited as some of the reasons for the staff cuts
Advertising

press releases

Loading latest Press Releases…

The best local and international journalism

handpicked and in your inbox every weekday